Trademark Alertz ®
Search
Trademark
Owner
Trademark: MTAMRIO 2047169
Word
MTAMRIO
ID
2047169
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
29 October 2019
Registration Date
29 October 2019
Renewal Date
29 October 2029
Owner(s)
Mirati Therapeutics, Inc The State of Delaware
Service
Knightsbridge Patent Attorneys
Goods and Services:
Class 5
:
Pharmaceuticals
;
pharmaceutical preparations
;
pharmaceutical products
;
pharmaceutical preparations for the treatment of cancer
;
pharmaceutical preparations for use in oncology
;
pharmaceutical preparations for the treatment of infectious diseases
;
pharmaceutical preparations for the treatment of bladder cancer
;
pharmaceutical preparations for the treatment of lung cancer
;
pharmaceutical preparations for the treatment of renal cancer
;
pharmaceutical preparations for the treatment of renal cell carcinoma
;
pharmaceutical preparations for the treatment of squamous cell carcinoma
;
pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma
;
pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma
;
pharmaceuticals comprising small molecules
;
pharmaceuticals comprising small molecules for the treatment of cancer
;
pharmaceuticals comprising small molecules for the treatment of bladder cancer
;
pharmaceuticals comprising small molecules for the treatment of lung cancer
;
pharmaceuticals comprising small molecules for the treatment of renal cancer
;
pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma
;
pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma
;
pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma
;
pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma
;
pharmaceuticals comprising compounds
;
pharmaceuticals comprising compounds for the treatment of cancer
;
pharmaceuticals comprising inhibitors
;
pharmaceuticals comprising inhibitors for the treatment of cancer
;
pharmaceuticals for the treatment of solid tumors
Class 42
:
Research and development of pharmaceuticals in the field of oncology
;
providing information in the field of scientific and medical research related to oncology
;
research and development of pharmaceuticals
;
providing information in the field of scientific and medical research related to pharmaceuticals
;
the provision of any one or more of these services on-line, including via a global communications, telecommunications or computer network, such as the Internet